Announced details
Research and development in aptamer drug discovery, and aptamer performance evaluation and design
Expected to contribute to more efficient and accurate research and development, although specific figures are not disclosed.
Joint research relationship. Capital and personnel relationships: not disclosed.
Shinjuku-ku, Tokyo; President: Tanaka Aiji (田中 愛治). Business activities, capital and year established: not disclosed.
Kobe International Conference Center (conference venue)
In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.
Nucleic Acids Research (published 14 January 2026, 54(2):gkaf1480) and the official IBS2026 URL (https://aeplan.jp/ibs2026/)
| Item | Details |
|---|---|
| Names of Products / Services Covered | RaptScore (an algorithm for aptamer evaluation using large language models) |
| Counterparty | Waseda University Educational Corporation |
| Counterparty overview | Shinjuku-ku, Tokyo; President: Tanaka Aiji (田中 愛治). Business activities, capital and year established: not disclosed. |
| Relationship with the Company | Joint research relationship. Capital and personnel relationships: not disclosed. |
| Launch date | 28 June to 2 July 2026 (conference presentation scheduled) |
| Applicable area | Research and development in aptamer drug discovery, and aptamer performance evaluation and design |
| Location | Kobe International Conference Center (conference venue) |
| Location scale | Approximately 1,000 people (conference attendees) |
| Quantitative Effects | Expected to contribute to more efficient and accurate research and development, although specific figures are not disclosed. |
| Source | Nucleic Acids Research (published 14 January 2026, 54(2):gkaf1480) and the official IBS2026 URL (https://aeplan.jp/ibs2026/) |
Items this document does not state (8)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.We believe this reflects international recognition of the research’s originality and academic value.